Equities

SOL SpA

SOL SpA

Actions
Basic MaterialsChemicals
  • Price (EUR)36.50
  • Today's Change0.300 / 0.83%
  • Shares traded132.74k
  • 1 Year change+38.00%
  • Beta0.5459
Data delayed at least 15 minutes, as of Jul 22 2024 16:35 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.

  • Revenue in EUR (TTM)1.49bn
  • Net income in EUR145.73m
  • Incorporated1990
  • Employees6.37k
  • Location
    SOL SpAVia Borgazzi, 27MONZA 20900ItalyITA
  • Phone+39 3923961
  • Fax+39 392396265
  • Websitehttps://www.sol.it/en
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Petkim Petrokimya Holding A.S.1.89bn225.41m1.71bn2.38k7.591.084.650.90673.203.2026.7622.550.875113.6310.38--10.475.8415.319.38-3.573.8811.976.450.5261--0.3784---38.2445.36677.1053.3432.68--
Robertet SA721.13m74.60m1.91bn2.36k23.354.1319.872.6535.7135.71345.20201.900.81281.825.34305,822.308.438.6610.3410.6139.7040.3210.3810.352.0613.870.411124.092.576.56-1.877.590.16228.70
Tessenderlo Group NV2.93bn109.50m2.13bn7.24k14.380.80516.800.72681.731.7346.4430.931.124.056.50404,349.604.396.745.388.4819.0624.303.916.551.3329.290.108417.7113.1712.56-51.743.6116.47--
K+S AG3.67bn-34.90m2.14bn11.42k--0.32874.870.5832-0.1731-0.171419.9736.340.38284.624.02320,485.70-0.3614.20-0.39895.016.8823.47-0.943111.211.59-0.41180.050118.81-31.78-0.8384-86.0837.89-1.3022.87
Lanxess AG6.42bn-950.00m2.25bn12.85k--0.492945.820.3496-11.004.5274.3752.750.57853.317.77499,805.40-8.561.25-11.381.5617.3223.80-14.791.801.36-2.190.397558.76-16.99-0.3245-557.61---8.09-35.56
Solvac SA135.23m127.34m2.32bn0.0018.210.9145--17.155.965.966.33118.640.0491--2.62--4.631.734.741.77101.75--94.1789.50----0.0732227.856.54-13.304.36-14.02--2.16
Kemira Oyj3.13bn179.20m3.23bn4.76k18.031.888.351.031.151.1520.2511.030.941--6.75637,700.905.785.267.937.04--36.506.145.581.0811.950.304559.20-5.215.47-14.0717.456.385.11
SOL SpA1.49bn145.73m3.25bn6.37k22.313.5010.932.191.611.6116.4010.240.81284.373.33233,386.108.357.4010.839.5672.8272.9510.279.301.9319.290.397222.137.8312.289.0122.9515.6016.15
HEXPOL AB1.84bn216.02m3.50bn5.08k16.952.6413.271.917.297.2962.0446.860.88277.096.164,227,102.0010.3711.1514.4714.8622.4420.9711.7511.560.860517.850.153567.44-0.88579.871.658.9327.0021.67
Umicore SA18.27bn385.08m3.52bn11.95k8.930.9394.840.19291.601.6075.9815.231.845.3711.461,528,782.003.794.756.247.888.246.292.061.900.82345.440.426429.80-28.195.90-32.433.9712.191.30
Solvay SA5.57bn59.00m3.67bn22.00k63.122.564.160.65850.548818.1052.9513.540.40713.003.94253,204.800.9940.73831.310.9522.3224.202.441.490.9646123.000.60891,903.46-24.50-11.82-116.21--5.02-8.31
Johnson Matthey PLC15.25bn128.27m3.70bn11.69k29.001.3110.390.24260.58620.586269.7012.941.928.188.311,099,101.001.622.682.724.757.226.680.84091.270.97114.640.38570.86-14.003.63-59.09-23.534.10-2.07
Data as of Jul 22 2024. Currency figures normalised to SOL SpA's reporting currency: Euro EUR

Institutional shareholders

13.85%Per cent of shares held by top holders
HolderShares% Held
Tweedy, Browne Co. LLCas of 31 Mar 20244.66m5.14%
Capital Research & Management Co. (World Investors)as of 30 Jun 20241.48m1.63%
The Vanguard Group, Inc.as of 04 Jul 20241.26m1.39%
Praude Asset Management Ltd.as of 31 Aug 20231.21m1.34%
Norges Bank Investment Managementas of 31 Dec 20231.21m1.34%
Eurizon Capital SGR SpAas of 29 Dec 2023646.79k0.71%
Arca Fondi SGR SpAas of 28 Jun 2024571.71k0.63%
Dimensional Fund Advisors LPas of 04 Jul 2024538.65k0.59%
Degroof Petercam Asset Management SAas of 28 Mar 2024492.13k0.54%
Amundi SGR SpAas of 31 May 2024482.22k0.53%
More ▼
Data from 31 Aug 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.